KC-2575

MC38-MSLN-Cell-Line

×
Please enable JavaScript in your browser to complete this form.
24332
Home » MC38-MSLN-Cell-Line

Background of MC38-MSLN-Cell-Line

MSLN (Mesothelin) is a cell-surface glycoprotein with normal expression in peritoneum, pleura, and pericardium, but with overexpression in a variety of cancers, including mesothelioma, pancreatic, lung, gastric, and ovarian cancers. It encodes a preproprotein that is proteolytically processed to generate two protein products, megakaryocyte potentiating factor and mesothelin. Mesothelin (MSLN) is an attractive antigen for chimeric antigen receptor (CAR) T therapy and the epitope selection within MSLN is essential. MSLN is an ideal cancer antigen for targeted immunotherapy. Diseases associated with MSLN include Benign Mesothelioma and Malignant Pleural Mesothelioma.

Specifications

Catalog NumberKC-2575
Cell Line NameMC38-MSLN-Cell-Line
Host Cell LineMouse MC38 cell line
DescriptionStable MC38 cell line expressing exogenous human MSLN gene
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% DMEM + 20% FBS + 10% DMSO
Propagation MediumDMEM + 10% FBS + 5μg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative
In Vivo ValidationYes

Cell Line Generation

MC38-MSLN cell line was generated using a lentiviral vector expressing the huamn MSLN sequence.

Characterization

Figure 1: Characterization of huamn MSLN overexpression in MC38 stable clones using FACS.

Figure 2: Characterization of MSLN in the MC38 MSLN stable clone using PCR sequencing.

Cell Resuscitation

  1. Prewarm culture medium (DMEM supplemented with 10% FBS and 5μg/mL puromycin)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Zhang, Z., Jiang, D., Yang, H. et al. Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor. Cell Death Dis 10, 476 (2019).10.
  2. Li Y, Tian W, Zhang H, Zhang Z, Zhao Q, Chang L, Lei N, Zhang W. MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer. Front Oncol. 2022 May 25;12:830570. doi: 10.3389/fonc.2022.830570. PMID: 35692779; PMCID: PMC9174524.
  3. He X, Wang L, Riedel H, Wang K, Yang Y, Dinu CZ, Rojanasakul Y. Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells. Mol Cancer. 2017 Mar 14;16(1):63. doi: 10.1186/s12943-017-0633-8. PMID: 28288645; PMCID: PMC5348784.
Please enable JavaScript in your browser to complete this form.